文献速递肝胆胰外科

机器人肝实质离断中剪刀肝切除术的安全性:队列研究

Safety of robotic hepatic parenchymal transection using scissor hepatectomy and alternative techniques: a cohort study.
PubMed 文献 · Surg Endosc · 2025-11-14

该研究基于单中心243例机器人肝切除术的前瞻性数据库,比较剪刀肝切除术与其他实质离断技术。207例符合标准患者中117例(57%)采用剪刀肝切除术,90例(43%)采用其他技术。剪刀肝切除术与更低的术中出血量相关,术后III级及以上并发症发生率两组相当(13% vs. 14%,p<0.99)。

要点

  • 剪刀肝切除术是安全的纯机器人肝实质离断技术。
  • 剪刀肝切除术与更低的术中出血量相关。
  • 术后III级及以上并发症发生率与替代技术相当。

核心结论

  • 剪刀肝切除术被证明是一种安全的纯机器人肝实质离断技术。
  • 需要前瞻性随机试验将该方法与其他肝实质离断技术进行比较。

研究设计与样本

  • 回顾性分析单中心243例连续机器人肝切除术患者的前瞻性数据库。
  • 按肝实质离断方式分为剪刀肝切除术组和替代技术组,采用倾向性评分匹配和逻辑回归分析。
  • 207例符合纳入标准,中位年龄64岁(55-70)。

主要发现

  • 117例(57%)采用剪刀肝切除术,90例(43%)采用替代技术(包括Bipolar、SynchroSeal、VesselSealer、Hydrojet和CUSA)。
  • 剪刀肝切除术在未匹配和匹配组(每组71例)中均与更低的术中出血量相关。
  • 术后III级及以上并发症发生率两组相当(13% vs. 14%,p<0.99)。
  • 未发现与术后III级及以上并发症相关的危险因素。

临床怎么用

  • 机器人肝切除术中可考虑采用剪刀肝切除术进行肝实质离断,其安全性与其他技术相当且出血量更低。

局限性

  • 本研究为单中心回顾性队列研究,非随机对照试验。
  • 需要前瞻性随机试验验证剪刀肝切除术与其他技术的比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Parenchymal transection represents a critical and challenging step in liver surgery. To date, there is no broadly accepted parenchymal transection technique in robotic liver surgery. This study aimed to compare the scissor hepatectomy technique to other parenchymal transection techniques. METHODS: A prospective database comprising 243 consecutive patients who underwent robotic hepatectomies at a single center was reviewed. The cohort was divided based on whether they received robotic parenchymal transection via scissor hepatectomy or alternative transection techniques. Propensity score matching and logistic regression analyses were carried out. RESULTS: Between 2020 and 2024, a total of 207 patients met the eligibility criteria with a median age of 64 years (55-70). Of these, 117 (57%) patients underwent parenchymal transection by scissor hepatectomy, while alternative transection techniques (including Bipolar, SynchroSeal, VesselSealer, Hydrojet, and CUSA) were utilized in 90 (43%) patients. SH was associated with lower intraoperative blood loss in both unmatched and matched groups (71 patients in each group). Postoperative Grade III or higher morbidity was comparable between groups (13% vs. 14%, p < 0.99). No risk factors were identified as being associated with Grade III or higher postoperative morbidity. CONCLUSION: Scissor hepatectomy is demonstrated to be a safe pure robotic parenchymal transection technique. Prospective randomized trials are warranted to compare this approach to other parenchymal transection techniques.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Miller E, Kassem A, Nasir N, et al. Safety of robotic hepatic parenchymal transection using scissor hepatectomy and alternative techniques: a cohort study. Surg Endosc. 2025. PMID: 41238990. doi:10.1007/s00464-025-12382-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。